Nurse Practitioner, Psychiatric/Mental Health · Green Bay, WI
NPI
1316011653
Since 2006
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1499 6th St
Green Bay, WI, 54304
Phone (920) 497-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
190 services
Medicare patients, 2024
29
Average age 46
Drug cost, 2024
$646K
2,050 prescriptions
Company payments, 2025
$2,540
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Glenda A McConnell was code 90833 (psychotherapy - nongroup), 95 times for 28 patients. In total Glenda A McConnell billed 190 services in 3 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90833 Psychotherapy - Nongroup | Office | 95 | 28 | $44.35 | $4,213 |
| 99215 Office E&M - Established | Office | 90 | 27 | $107.44 | $9,669 |
By year: 2022 $15K for 205 services; 2023 $13K for 171 services; 2024 $15K for 190 services.
Medicare prescription drug claims, 2024
In 2024, the drug Glenda A McConnell prescribed most often to Medicare patients was Vyvanse (Lisdexamfetamine Dimesylate), with 179 prescriptions and refills. In total Glenda A McConnell wrote 2,050 Medicare prescriptions that cost $646K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyvanse Lisdexamfetamine Dimesylate | 179 | 179 | 23 | $92K |
| Clonazepam Generic | 164 | 170 | 27 | $2,019 |
| Lamotrigine Generic | 128 | 181 | 23 | $2,610 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 94 | 94 | 13 | $9,213 |
| Lorazepam Generic | 92 | 92 | 19 | $310 |
| Rexulti Brexpiprazole | 82 | 84 | 11 | $135K |
| Trazodone Hcl Generic | 81 | 109 | 13 | $653 |
| Alprazolam Generic | 80 | 88 | 14 | $344 |
| Vraylar Cariprazine Hcl | 76 | 76 | 12 | $101K |
| Hydroxyzine Hcl Generic | 71 | 85 | 13 | $2,451 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 67 | 67 | Under 11 | $2,574 |
| Bupropion Xl Bupropion Hcl | 66 | 100 | 12 | $1,278 |
| Duloxetine Hcl Generic | 53 | 74 | Under 11 | $952 |
| Lurasidone Hcl Generic | 50 | 50 | Under 11 | $1,944 |
| Sertraline Hcl Generic | 45 | 65 | Under 11 | $442 |
Brand drugs: 522 claims; generic drugs: 1,528 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Glenda A McConnell $2,540 ($2,540 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $488.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $488 |
| Alkermes, Inc. ALKS | 16 | $304 |
| Supernus Pharmaceuticals, Inc. SUPN | 21 | $280 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $272 |
| Axsome Therapeutics, Inc. AXSM | 22 | $255 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $196 |
| Lundbeck LLC | 6 | $120 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $108 |
| Vanda Pharmaceuticals Inc. VNDA | 5 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.